Skip to main content
Equibles

Pale Fire Capital SE

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1922318 Prague, 2N
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$131,150
-$41,130 QoQ
Shares Held
43,000
-4.9% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 162 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pale Fire Capital SE holds $45,363,888 across 27 Biotechnology names. LRMR ranks #24 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MLYS
Mineralys Therapeutics, Inc.
 614,284 $16,573,382
2 GERN
Geron Corp
 5,307,204 $6,793,221
3 RGNX
REGENXBIO Inc.
 466,209 $5,585,183
4 GUTS
Fractyl Health, Inc.
 5,003,237 $3,972,570
5 SNDX
Syndax Pharmaceuticals Inc
 125,550 $2,744,523
6 SGMT
Sagimet Biosciences Inc.
 221,875 $1,715,093
7 HRTX
Heron Therapeutics, Inc. /De/
 2,511,478 $1,079,935
8 HELP
Cybin Inc.
 153,505 $1,014,668

All Filings in LRMR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $131,150 43,000
2025-12-31 $172,280 45,218
2025-09-30 $146,054 45,218
2025-06-30 $108,427 37,518
2025-03-31 $80,663 37,518
2024-12-31 $125,035 32,309
2024-09-30 $211,623 32,309
2024-06-30 $103,617 14,292
2023-12-31 $54,782 12,040
2023-09-30 $47,558 12,040